According to information from the New York Stock Exchange, international tobacco company Philip Morris (code: PM) has performed well in the stock market, with a market value of 160.4 billion US dollars (about 1.1 trillion Chinese yuan) and a dividend yield of 4.91%.
Philip Morris International is one of the largest tobacco companies in the market. Its products are sold in over 180 countries and territories, with a portfolio that includes top-selling tobacco product brands such as Marlboro, L&M, Chesterfield, and IQOS, among others. Its success is demonstrated in its market value of over $160 billion (equivalent to approximately 1.1 trillion yuan), making it part of the S&P 500 index.
Note: The S&P 500 Index is an abbreviated term for the Standard & Poor's 500 Index, which is a stock index that tracks 500 publicly traded companies in the United States.
The stock market graph for Fimo International is sourced from FINEX.CZ.
Phemo International has faced criticism in the past for selling products that have negative impacts on human health. As a result, the company has decided to diversify its business by developing healthier alternative products.
However, Phimo International is still engaged in the business of new tobacco, and there are no signs that this situation will change in the future. In addition, only a few countries have shown a positive attitude towards the solution proposed by New Zealand, which no longer plans to provide tobacco products to the younger generation.
It is noteworthy that Filmo International operates in regions where the number of smokers is rapidly increasing, resulting in a growing customer base each year. Investors also find the 5% annual dividend yield satisfying, which has been steadily increasing for the past decade. Additionally, Filmo International's Czech subsidiary offers high-quality dividends.
Special Note: This article is not intended to offer any investment advice or recommendations.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
